DOCSLIB.ORG

Natural Bioactive Compounds As Inhibitors of Cancer Targets

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Natural Bioactive Compounds As Inhibitors of Cancer Targets NATURAL BIOACTIVE COMPOUNDS AS INHIBITORS OF CANCER TARGETS WILSON MALDONADO ROJAS MSc. NATURAL BIOACTIVE COMPOUNDS AS INHIBITORS OF CANCER TARGETS WILSON MALDONADO ROJAS MSc. UNIVERSITY OF CARTAGENA SCHOOL OF PHARMACEUTICAL SCIENCES Ph.D. PROGRAM IN ENVIRONMENTAL TOXICOLOGY CARTAGENA DE INDIAS 2016 NATURAL BIOACTIVE COMPOUNDS AS INHIBITORS OF CANCER TARGETS WILSON MALDONADO ROJAS MSc. This work is a document submitted as a requirement for obtain Ph.D. In Environmental Toxicology Prof. JESÚS OLIVERO VERBEL. Ph.D. Director Environmental and Computational Chemistry Group University of Cartagena UNIVERSITY OF CARTAGENA SCHOOL OF PHARMACEUTICAL SCIENCES Ph.D. PROGRAM IN ENVIRONMENTAL TOXICOLOGY CARTAGENA DE INDIAS 2016 CAUTIONARY NOTE The University is not responsible for the items issued by students in their thesis work. Only ensure that nothing contrary is published to dogma and Catholic morals and because the theses do not contain personal attacks against someone, rather look in them the desire to seek truth and justice. "Article 23 of Resolution 13, July 1946 . ACCEPTANCE NOTE __________________________ __________________________ __________________________ __________________________ Jury President __________________________ Jury __________________________ Jury __________________________ Jury Cartagena de Indias, 04th August 2016 DEDICATION To God who created the universe, manager and participant in each of my plans and dreams, by which it was possible to reach this achievement... To my mother Emilse Rojas Blanco and my father Antonio Maldonado Rodriguez for being my motivation to excel at all times, teaching me the real value of things, the perseverance to achieve the proposed goals, and even when they are not with me right now, I remember them at all times and dedicatethis triumph from the bottom of my heart... To Liliana Amaya, mother of my three beautiful daughters Carolina, Paula Andrea, and my little Valeria, who are my main motivation, my most precious treasures, and constant source of warmth, tenderness and love... To my brothers Oscar, Antonio, Luis Alfonso and Luz Marina, and my whole family for the unconditional support given in all these years of hard work and dedication despite the adversities... To All my friends and colleagues for their help... This is for you all. ACKNOWLEDGMENTS Firstly, I would like to express my gratitude to God for giving me the strength and the ability to move forward in every step of my personal training, for his immense compassion and incomparable love, to him be glory and honor forever. Besides God, I would also like to thank my family for their support, motivation, confidence and time, many thanks indeed have been each of you builders of this achievement. My sincere thanks to Professor Jesus Olivero Verbel, my advisor and friend, for his teachings, advices, patience, unconditional support in good and bad times , and the opportunity provided to know and let me be part of his workgroup, and to grow professionally and personally taught by knowledge and high regard, thank you for everything. To all members of the Environmental and Computational Chemistry Group, an excellent group of people and professionals thanks to all without exception, for its immense collaboration. To undergraduate students María Isabel Olivero, Juan Carlos Salinas, Jessica Cerón, Joyce Ramírez, young researchers Karen Rivera, Nadia Coronado, Juan David Sierra, Alejandra Manjarres, Angela Bertel Sevilla and Ricardo Hernandez. To all my professors from the Ph.D program in Environmental Toxicology, especially Prof. Boris Johnson Restrepo, for all his knowledge and advice during the project, and Prof. Yovanni Marrero Ponce, for his valuable support throughout my training in the DTA, the confidence, advices and knowledge transmitted. To all personnel at the School of Pharmaceutical Sciences, administratives and all staff in general. To the University of Cartagena, alma mater, thank you very much for giving me the opportunity to continue my training process. I also want to thank Professor Enrique Melendez, an extraordinary scientist and a great person, for giving me the opportunity to work with his research group at the University of Puerto Rico, Mayaguez, as well as, his team of researchers, Xiomara Narvaez, José Carmona and Moralba Dominguez, for their great disposition and patience to train me, and give me part of their knowledge to achieve some of the results presented in this thesis. I would also like to thank people from other research groups who helped me with the activities of my project in my international internship in Puerto Rico, some of them are Carlos Ortega, Leonardo Pacheco, Jorge Guette, Jose Luis Ruiz and Andres Roman. And to all those who supported and believed in me, thanks a lot. Finally, I wish to thank to the University of Cartagena, Cartagena (Colombia); as well as as the program for supporting research groups, third call for mobility of students from research groups at the University of Cartagena, 2014 sponsored by the Vice-Rectory for Research of the University of Cartagena (2013–2016), CENIVAM (RC-0572-7-2012) and the National Program for Doctoral Studies in Colombia (Colciencias, 528-2011). Natural Bioactive Compounds as Inhibitors of Cancer Targets. Ph.D. In Environmental Toxicology CONTENTS ABSTRACT ....................................................................................................................... 15 RESUMEN ........................................................................................................................ 17 CHAPTER 1. THESIS OVERVIEW ................................................................................... 22 1.1 RATIONALE ........................................................................................................... 22 1.2. HYPOTHESIS ....................................................................................................... 25 1.3. PERTINENCE ....................................................................................................... 25 1.4. OBJECTIVES AND THESIS STRUCTURE .......................................................... 27 1.5. REFERENCES ...................................................................................................... 28 CHAPTER 2. INTRODUCTION TO THE CANCER .......................................................... 35 2.1. CANCER OVERVIEW ........................................................................................... 35 2.2. DNA METHYLATION IN SKIN CANCER .............................................................. 37 2.3. MOLECULAR PROTEIN-LIGAND DOCKING ....................................................... 38 2.4. NATURALLY OCCURRING COMPOUNDS AND THEIR APPLICATION IN MEDICINE .......................................................................................................................... 39 2.5. MOLECULAR BIOLOGY ASSAYS (PCR/RFLP) .................................................. 40 2.6. CELL VIABILITY ASSAYS .................................................................................... 41 2.7. SPECTROSCOPIC METHODS USED TO EVALUATE PROTEIN-LIGAND INTERACTIONS ................................................................................................................. 41 2.8. REFERENCES ...................................................................................................... 42 CHAPTER 3. POTENTIAL INTERACTION OF NATURAL DIETARY BIOACTIVE COMPOUNDS WITH COX-2 .................................................................................................. 49 3.1. ABSTRACT ........................................................................................................... 49 3.2. INTRODUCTION ................................................................................................... 50 3.3. MATERIALS AND METHODS .............................................................................. 50 3.4. RESULTS AND DISCUSSION .............................................................................. 54 3.5. CONCLUSIONS .................................................................................................... 67 3.6. REFERENCES ...................................................................................................... 67 CHAPTER 4. FOOD-RELATED COMPOUNDS THAT MODULATE EXPRESSION OF INDUCIBLE NITRIC OXIDE SYNTHASE MAY ACT AS ITS INHIBITORS ............................. 77 4.1. ABSTRACT ........................................................................................................... 77 4.2. INTRODUCTION ................................................................................................... 78 9 Natural Bioactive Compounds As Inhibitors Of Cancer Targets. Ph.D. In Environmental Toxicology 4.3. MATERIALS AND METHODS .............................................................................. 79 4.4. RESULTS AND DISCUSSION .............................................................................. 82 4.5. CONCLUSIONS .................................................................................................... 90 4.6. REFERENCES ...................................................................................................... 91 CHAPTER 5. COMPUTATIONAL FISHING OF NEW DNA METHYLTRANSFERASE INHIBITORS FROM NATURAL PRODUCTS ......................................................................... 99 5.1. ABSTRACT ........................................................................................................... 99 5.2. INTRODUCTION ................................................................................................
Load more

Recommended publications
  • Open Data, Open Source, and Open Standards in Chemistry: the Blue Obelisk Five Years On" Journal of Cheminformatics Vol
    Oral Roberts University Digital Showcase College of Science and Engineering Faculty College of Science and Engineering Research and Scholarship 10-14-2011 Open Data, Open Source, and Open Standards in Chemistry: The lueB Obelisk five years on Andrew Lang Noel M. O'Boyle Rajarshi Guha National Institutes of Health Egon Willighagen Maastricht University Samuel Adams See next page for additional authors Follow this and additional works at: http://digitalshowcase.oru.edu/cose_pub Part of the Chemistry Commons Recommended Citation Andrew Lang, Noel M O'Boyle, Rajarshi Guha, Egon Willighagen, et al.. "Open Data, Open Source, and Open Standards in Chemistry: The Blue Obelisk five years on" Journal of Cheminformatics Vol. 3 Iss. 37 (2011) Available at: http://works.bepress.com/andrew-sid-lang/ 19/ This Article is brought to you for free and open access by the College of Science and Engineering at Digital Showcase. It has been accepted for inclusion in College of Science and Engineering Faculty Research and Scholarship by an authorized administrator of Digital Showcase. For more information, please contact [email protected]. Authors Andrew Lang, Noel M. O'Boyle, Rajarshi Guha, Egon Willighagen, Samuel Adams, Jonathan Alvarsson, Jean- Claude Bradley, Igor Filippov, Robert M. Hanson, Marcus D. Hanwell, Geoffrey R. Hutchison, Craig A. James, Nina Jeliazkova, Karol M. Langner, David C. Lonie, Daniel M. Lowe, Jerome Pansanel, Dmitry Pavlov, Ola Spjuth, Christoph Steinbeck, Adam L. Tenderholt, Kevin J. Theisen, and Peter Murray-Rust This article is available at Digital Showcase: http://digitalshowcase.oru.edu/cose_pub/34 Oral Roberts University From the SelectedWorks of Andrew Lang October 14, 2011 Open Data, Open Source, and Open Standards in Chemistry: The Blue Obelisk five years on Andrew Lang Noel M O'Boyle Rajarshi Guha, National Institutes of Health Egon Willighagen, Maastricht University Samuel Adams, et al.
    [Show full text]
  • A Java-Based Platform for Evolutionary De Novo Molecular Design
    Article MoleGear: A Java-Based Platform for Evolutionary De Novo Molecular Design Yunhan Chu and Xuezhong He * Department of Chemical Engineering, Norwegian University of Science and Technology, N-7491 Trondheim, Norway; [email protected] * Correspondence: [email protected]; Tel.: +47-73593942 Received: 25 March 2019; Accepted: 10 April 2019; Published: 11 April 2019 Abstract: A Java-based platform, MoleGear, is developed for de novo molecular design based on the chemistry development kit (CDK) and other Java packages. MoleGear uses evolutionary algorithm (EA) to explore chemical space, and a suite of fragment-based operators of growing, crossover, and mutation for assembling novel molecules that can be scored by prediction of binding free energy or a weighted-sum multi-objective fitness function. The EA can be conducted in parallel over multiple nodes to support large-scale molecular optimizations. Some complementary utilities such as fragment library design, chemical space analysis, and graphical user interface are also integrated into MoleGear. The candidate molecules as inhibitors for the human immunodeficiency virus 1 (HIV-1) protease were designed by MoleGear, which validates the potential capability for de novo molecular design. Keywords: de novo design; evolutionary algorithm; drug molecules; fitness; multi-objective function 1. Introduction Computational chemistry plays an important role in the design of new drug-like molecules [1– 5], catalysts [6–8], and novel solvents of ionic liquids [9–11]. De novo molecular design has been an active research area of drug design/discovery over the last decades, and many approaches such as LUDI [12], LEA3D [13], Flux [14,15], and pharmacophore-linked fragment virtual screening (PFVS) [16] have been developed by using protein and ligand structures.
    [Show full text]
  • Molecular Structure Input on the Web Peter Ertl
    Ertl Journal of Cheminformatics 2010, 2:1 http://www.jcheminf.com/content/2/1/1 REVIEW Open Access Molecular structure input on the web Peter Ertl Abstract A molecule editor, that is program for input and editing of molecules, is an indispensable part of every cheminfor- matics or molecular processing system. This review focuses on a special type of molecule editors, namely those that are used for molecule structure input on the web. Scientific computing is now moving more and more in the direction of web services and cloud computing, with servers scattered all around the Internet. Thus a web browser has become the universal scientific user interface, and a tool to edit molecules directly within the web browser is essential. The review covers a history of web-based structure input, starting with simple text entry boxes and early molecule editors based on clickable maps, before moving to the current situation dominated by Java applets. One typical example - the popular JME Molecule Editor - will be described in more detail. Modern Ajax server-side molecule editors are also presented. And finally, the possible future direction of web-based molecule editing, based on tech- nologies like JavaScript and Flash, is discussed. Introduction this trend and input of molecular structures directly A program for the input and editing of molecules is an within a web browser is therefore of utmost importance. indispensable part of every cheminformatics or molecu- In this overview a history of entering molecules into lar processing system. Such a program is known as a web applications will be covered, starting from simple molecule editor, molecular editor or structure sketcher.
    [Show full text]
  • Reduced Renal Methylarginine Metabolism Protects Against Progressive Kidney Damage
    BASIC RESEARCH www.jasn.org Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage † James A.P. Tomlinson,* Ben Caplin, Olga Boruc,* Claire Bruce-Cobbold,* Pedro Cutillas,* † ‡ Dirk Dormann,* Peter Faull,* Rebecca C. Grossman, Sanjay Khadayate,* Valeria R. Mas, † | Dorothea D. Nitsch,§ Zhen Wang,* Jill T. Norman, Christopher S. Wilcox, † David C. Wheeler, and James Leiper* *Medical Research Council Clinical Sciences Centre, Imperial College, London, United Kingdom; †Centre for Nephrology, UCL Medical School Royal Free, London, United Kingdom; ‡Translational Genomics Transplant Laboratory, Transplant Division, Department of Surgery, University of Virginia, Charlottesville, Virginia; §Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom; and |Hypertension, Kidney and Vascular Research Center, Georgetown University, Washington, DC ABSTRACT Nitric oxide (NO) production is diminished in many patients with cardiovascular and renal disease. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NO synthesis, and elevated plasma levels of ADMA are associated with poor outcomes. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is a methylarginine- metabolizing enzyme that reduces ADMA levels. We reported previously that a DDAH1 gene variant associated with increased renal DDAH1 mRNA transcription and lower plasma ADMA levels, but counterintuitively, a steeper rate of renal function decline. Here, we test the hypothesis that reduced renal-specific
    [Show full text]
  • Designing Universal Chemical Markup (UCM) Through the Reusable Methodology Based on Analyzing Existing Related Formats
    Designing Universal Chemical Markup (UCM) through the reusable methodology based on analyzing existing related formats Background: In order to design concepts for a new general-purpose chemical format we analyzed the strengths and weaknesses of current formats for common chemical data. While the new format is discussed more in the next article, here we describe our software s t tools and two stage analysis procedure that supplied the necessary information for the n i r development. The chemical formats analyzed in both stages were: CDX, CDXML, CML, P CTfile and XDfile. In addition the following formats were included in the first stage only: e r P CIF, InChI, NCBI ASN.1, NCBI XML, PDB, PDBx/mmCIF, PDBML, SMILES, SLN and Mol2. Results: A two stage analysis process devised for both XML (Extensible Markup Language) and non-XML formats enabled us to verify if and how potential advantages of XML are utilized in the widely used general-purpose chemical formats. In the first stage we accumulated information about analyzed formats and selected the formats with the most general-purpose chemical functionality for the second stage. During the second stage our set of software quality requirements was used to assess the benefits and issues of selected formats. Additionally, the detailed analysis of XML formats structure in the second stage helped us to identify concepts in those formats. Using these concepts we came up with the concise structure for a new chemical format, which is designed to provide precise built-in validation capabilities and aims to avoid the potential issues of analyzed formats.
    [Show full text]
  • Open Data, Open Source and Open Standards in Chemistry: the Blue Obelisk five Years On
    Open Data, Open Source and Open Standards in chemistry: The Blue Obelisk ¯ve years on Noel M O'Boyle¤1 , Rajarshi Guha2 , Egon L Willighagen3 , Samuel E Adams4 , Jonathan Alvarsson5 , Richard L Apodaca6 , Jean-Claude Bradley7 , Igor V Filippov8 , Robert M Hanson9 , Marcus D Hanwell10 , Geo®rey R Hutchison11 , Craig A James12 , Nina Jeliazkova13 , Andrew SID Lang14 , Karol M Langner15 , David C Lonie16 , Daniel M Lowe4 , J¶er^omePansanel17 , Dmitry Pavlov18 , Ola Spjuth5 , Christoph Steinbeck19 , Adam L Tenderholt20 , Kevin J Theisen21 , Peter Murray-Rust4 1Analytical and Biological Chemistry Research Facility, Cavanagh Pharmacy Building, University College Cork, College Road, Cork, Co. Cork, Ireland 2NIH Center for Translational Therapeutics, 9800 Medical Center Drive, Rockville, MD 20878, USA 3Division of Molecular Toxicology, Institute of Environmental Medicine, Nobels vaeg 13, Karolinska Institutet, 171 77 Stockholm, Sweden 4Unilever Centre for Molecular Sciences Informatics, Department of Chemistry, University of Cambridge, Lens¯eld Road, CB2 1EW, UK 5Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 751 24 Uppsala, Sweden 6Metamolecular, LLC, 8070 La Jolla Shores Drive #464, La Jolla, CA 92037, USA 7Department of Chemistry, Drexel University, 32nd and Chestnut streets, Philadelphia, PA 19104, USA 8Chemical Biology Laboratory, Basic Research Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, MD 21702, USA 9St. Olaf College, 1520 St. Olaf Ave., North¯eld, MN 55057, USA 10Kitware, Inc., 28 Corporate Drive, Clifton Park, NY 12065, USA 11Department of Chemistry, University of Pittsburgh, 219 Parkman Avenue, Pittsburgh, PA 15260, USA 12eMolecules Inc., 380 Stevens Ave., Solana Beach, California 92075, USA 13Ideaconsult Ltd., 4.A.Kanchev str., So¯a 1000, Bulgaria 14Department of Engineering, Computer Science, Physics, and Mathematics, Oral Roberts University, 7777 S.
    [Show full text]
  • By Norepinephrine and Inactivated by NO and Cgmp (Medial Basal Hypothalami/Luteinizing Hormone-Releasing Hormone/Camp/Arginine/Nitroarginine Methyl Ester) G
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 4246-4250, April 1996 Physiology Nitric oxide synthase content of hypothalamic explants: Increased by norepinephrine and inactivated by NO and cGMP (medial basal hypothalami/luteinizing hormone-releasing hormone/cAMP/arginine/nitroarginine methyl ester) G. CANTEROS*, V. RErroRI*, A. GENARO*, A. SUBURO*, M. GIMENO*, AND S. M. MCCANNtt *Centro de Estudios Farmacologicos y Botanicos, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Serrano 665, 1414 Buenos Aires, Argentina; and tPennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, LA 70808-4124 Contributed by S. M. McCann, December 26, 1995 ABSTRACT Release of luteinizing hormone (LH)- pituitary gland. There it releases LH, which induces ovulation releasing hormone (LHRH), the hypothalamic peptide that and ovarian steroid secretion in females and testosterone controls release of LH from the adenohypophysis, is con- secretion in males (3). Since NO controls LHRH release in the trolled by NO. There is a rich plexus of nitric oxide synthase arcuate nucleus-median eminence region, where axons of (NOS)-containing neurons and fibers in the lateral median LHRH neurons terminate on the portal capillaries (2), we eminence, intermingled with terminals of the LHRH neurons. expected to find NOergic neurons in this region. Indeed, in the To study relations between NOS and LHRH in this brain present study we found a large number of NOergic cell bodies region, we measured NOS activity in incubated medial basal and fibers in the arcuate-median eminence region. hypothalamus (MBH). NOS converts [l4C]arginine to equimo- This study was initiated to determine if we could measure lar quantities of [14C]citrulline plus NO, which rapidly decom- NOS activity in incubated medial basal hypothalami (MBHs) poses.
    [Show full text]
  • Biomolecular Simulation Data Management In
    BIOMOLECULAR SIMULATION DATA MANAGEMENT IN HETEROGENEOUS ENVIRONMENTS Julien Charles Victor Thibault A dissertation submitted to the faculty of The University of Utah in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Biomedical Informatics The University of Utah December 2014 Copyright © Julien Charles Victor Thibault 2014 All Rights Reserved The University of Utah Graduate School STATEMENT OF DISSERTATION APPROVAL The dissertation of Julien Charles Victor Thibault has been approved by the following supervisory committee members: Julio Cesar Facelli , Chair 4/2/2014___ Date Approved Thomas E. Cheatham , Member 3/31/2014___ Date Approved Karen Eilbeck , Member 4/3/2014___ Date Approved Lewis J. Frey _ , Member 4/2/2014___ Date Approved Scott P. Narus , Member 4/4/2014___ Date Approved And by Wendy W. Chapman , Chair of the Department of Biomedical Informatics and by David B. Kieda, Dean of The Graduate School. ABSTRACT Over 40 years ago, the first computer simulation of a protein was reported: the atomic motions of a 58 amino acid protein were simulated for few picoseconds. With today’s supercomputers, simulations of large biomolecular systems with hundreds of thousands of atoms can reach biologically significant timescales. Through dynamics information biomolecular simulations can provide new insights into molecular structure and function to support the development of new drugs or therapies. While the recent advances in high-performance computing hardware and computational methods have enabled scientists to run longer simulations, they also created new challenges for data management. Investigators need to use local and national resources to run these simulations and store their output, which can reach terabytes of data on disk.
    [Show full text]
  • S-Nitrosylation Drives Cell Senescence and Aging in Mammals By
    S-nitrosylation drives cell senescence and aging in PNAS PLUS mammals by controlling mitochondrial dynamics and mitophagy Salvatore Rizzaa,1, Simone Cardacib,1, Costanza Montagnaa,c,1, Giuseppina Di Giacomod,2, Daniela De Zioa, Matteo Bordid, Emiliano Maiania, Silvia Campellod,e, Antonella Borrecaf, Annibale A. Pucag,h, Jonathan S. Stamleri,j, Francesco Cecconia,d,k, and Giuseppe Filomenia,d,3 aDanish Cancer Society Research Center, Center for Autophagy, Recycling and Disease, 2100 Copenhagen, Denmark; bDivision of Genetics and Cell Biology, Institute for Research and Health Care San Raffaele (IRCCS) Scientific Institute, 20132 Milan, Italy; cInstitute of Sports Medicine Copenhagen, Bispebjerg Hospital, 2400 Copenhagen, Denmark; dDepartment of Biology, Tor Vergata University, 00133 Rome, Italy; eIRCCS Fondazione Santa Lucia, 00146 Rome, Italy; fInstitute of Cellular Biology and Neuroscience, National Research Council, 00143 Rome, Italy; gCardiovascular Research Unit, IRCCS Multimedica, 20138 Milan, Italy; hDipartimento di Medicina e Chirurgia, University of Salerno, 84084 Fisciano Salerno, Italy; iInstitute for Transformative Molecular Medicine, Case Western Reserve University, Cleveland, OH 44106; jHarrington Discovery Institute, University Hospitals Case Medical Center, Cleveland, OH 44106; and kDepartment of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children’s Hospital, 00146 Rome, Italy Edited by Solomon H. Snyder, Johns Hopkins University School of Medicine, Baltimore, MD, and approved March 1, 2018 (received for review January 9, 2018) S-nitrosylation, a prototypic redox-based posttranslational modifi- found in experimental models of aging, supporting the idea that cation, is frequently dysregulated in disease. S-nitrosoglutathione GSNOR preserves cellular function. reductase (GSNOR) regulates protein S-nitrosylation by function- The free radical theory of aging postulates that oxidative ing as a protein denitrosylase.
    [Show full text]
  • Proceeding of the Symposium NITRIC OXIDE Basic Regulations And
    Proceeding of the Symposium NITRIC OXIDE Basic Regulations and Pharmacological Interventions September 21-24, 2005, Tucepi, Croatia Abstracts are presented in the alphabetical order of the first author names and are printed without editing in the submitted form. The Editorial Office of Physiological Research disclaims any responsibility for errors that may have been made in abstracts submitted by the authors. Vol. 55 Physiol. Res. 2006 1P VASODILATORY RESPONS ES UNDER HYPOXIC responses of myocardium to NOD and in adaptive responses of these CONDITION: ROLE OF PGI2 AND NO hearts to ischemic stress. The results point also to the possible I. Juránek, V. Bauer, J. Donnerer1, F. Lembeck1, B.A. Peskar1 relationship between ERK pathway and activation of eNOS and/or Institute of Experimental Pharmacology, Slovak Academy of Sciences, tissue MMP-2. Bratislava, Slovakia; 1Institute of Experimental and Clinical 1. Strohm et. al., J. Cardiovasc. Pharmacol. 2000, 36:218-229 Pharmacology, Medical University, Graz, Austria. Supported by VEGA SR No 2/3123/25, 2/5110/25, APVT 51-013802, SP51/0280900/ 0280901, SP51/028000/0280802. Aim of the present study was to test hypothesis that low availability of oxygen in hypoxic tissue should inhibit oxygenation of arachidonic acid and thereby result in inhibition of eicosanoid synthesis in vivo. Perfusion of the isolated rabbit ear with normoxic or hypoxic medium DUAL ROLE OF NO IN SUSCEPTIBILITY TO ISCHEMIA/ was applied. Eicosanoid biosynthesis and functional responses of the REPERFUSION INJURY IN THE RAT HEART vascular bed were followed. Simultaneous recording of prostaglandin I2 E. Andelová, M. Pintérová, P. Šimoncíková, M. Barancík, M. release and peripheral resistance of t he preparation revealed that lack of Ondrejcáková, *O.
    [Show full text]
  • Viagra, INN-Sildenafil
    SCIENTIFIC DISCUSSION This module reflects the initial scientific discussion for the approval of VIAGRA. This scientific discussion has been updated until 1 December 2002. For information on changes after this date please refer to module 8B. 1. Introduction Male erectile dysfunction (ED) has been defined as the inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance as part of the overall process of male sexual function (NIH Consensus Conference, 1993). ED can have a profound impact on the quality of life with subjects often reporting increased anxiety, loss of self-esteem, lack of self-confidence, tension and difficulty in the relationship with their partner. The prevalence of ED has been found to be associated with age. Complete ED has an estimated prevalence of about 5% in men aged 40 years to 15% at age 70 years. It should be recognised that desire, orgasmic capacity and ejaculatory capacity may be intact even in the presence of erectile dysfunction or may be deficient to some extent and contribute to the sense of inadequate sexual function. The term impotence, together with its pejorative implications, is less precise and should not be used. The degree of erectile dysfunction can vary and may range from a partial decrease in penile rigidity to complete erectile failure and the frequency of these failures may also range from “a few times a year” to “usually unable to obtain an erection”. ED is often multifactorial in etiology (organic, psychogenic, or mixed). Sometimes ED is related to stress problems with the sexual partner or transient psychological factors.
    [Show full text]
  • Maternal Tadalafil Therapy for Fetal Growth Restriction Prevents Non
    www.nature.com/scientificreports OPEN Maternal tadalafl therapy for fetal growth restriction prevents non‑alcoholic fatty liver disease and adipocyte hypertrophy in the ofspring Takuya Kawamura, Hiroaki Tanaka, Ryota Tachibana, Kento Yoshikawa, Shintaro Maki, Kuniaki Toriyabe, Hiroki Takeuchi, Shinji Katsuragi, Kayo Tanaka* & Tomoaki Ikeda We aimed to investigate the efects of maternal tadalafl therapy on fetal programming of metabolic function in a mouse model of fetal growth restriction (FGR). Pregnant C57BL6 mice were divided into the control, L‑NG‑nitroarginine methyl ester (L‑NAME), and tadalafl + L‑NAME groups. Six weeks after birth, the male pups in each group were given a high‑fat diet. A glucose tolerance test (GTT) was performed at 15 weeks and the pups were euthanized at 20 weeks. We then assessed the histological changes in the liver and adipose tissue, and the adipocytokine production. We found that the non‑alcoholic fatty liver disease activity score was higher in the L‑NAME group than in the control group (p < 0.05). Although the M1 macrophage numbers were signifcantly higher in the L‑NAME/ high‑fat diet group (p < 0.001), maternal tadalafl administration prevented this change. Moreover, the epididymal adipocyte size was signifcantly larger in the L‑NAME group than in the control group. This was also improved by maternal tadalafl administration (p < 0.05). Further, we found that resistin levels were signifcantly lower in the L‑NAME group compared to the control group (p < 0.05). The combination of exposure to maternal L‑NAME and a high‑fat diet induced glucose impairment and non‑alcoholic fatty liver disease.
    [Show full text]